Nicholas J. Willumsen

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.

Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: August 21, 2026

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

Journal: Cancers

Published: July 10, 2026

Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.

Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.

Journal: BMC medicine

Published: February 04, 2026

Serum levels of the C-terminal pro-peptide of type V collagen have prognostic potential and are associated with a normal subtype of desmoplasia in a retrospective cohort of patients with esophagogastric cancer.

Serum levels of the C-terminal pro-peptide of type V collagen have prognostic potential and are associated with a normal subtype of desmoplasia in a retrospective cohort of patients with esophagogastric cancer.

Journal: Therapeutic advances in medical oncology

Published: January 26, 2026

Circulating EMID2 as a Prognostic Biomarker of Poor Outcomes in Patients with Metastatic Colorectal Cancer.

Circulating EMID2 as a Prognostic Biomarker of Poor Outcomes in Patients with Metastatic Colorectal Cancer.

Journal: Biomarker insights

Published: November 25, 2025

Collagen-derived biomarkers reveal distinct fibrotic responses among cancer-associated fibroblasts.

Collagen-derived biomarkers reveal distinct fibrotic responses among cancer-associated fibroblasts.

Journal: Scientific reports

Published: September 15, 2025

BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target.

BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target.

Journal: Scientific reports

Published: July 08, 2025

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Journal: BMC cancer

Published: March 21, 2025

Markers of Collagen Formation and Degradation in Serum and Pancreatic Fluid Collections in Patients With Acute and Chronic Pancreatitis.

Markers of Collagen Formation and Degradation in Serum and Pancreatic Fluid Collections in Patients With Acute and Chronic Pancreatitis.

Journal: Pancreas

Published: February 10, 2025

Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.

Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.

Journal: Journal of clinical medicine

Published: December 20, 2024

Collagen turnover biomarkers to predict outcome of patients with biliary cancer.

Collagen turnover biomarkers to predict outcome of patients with biliary cancer.

Journal: BMC gastroenterology

Published: August 15, 2024

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 19, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026